KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Intangibles (2021 - 2025)

Fulgent Genetics (FLGT) has disclosed Intangibles for 5 consecutive years, with $64.8 million as the latest value for Q4 2025.

  • Quarterly Intangibles fell 7.95% to $64.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $64.8 million through Dec 2025, down 7.95% year-over-year, with the annual reading at $64.8 million for FY2025, 7.95% down from the prior year.
  • Intangibles hit $64.8 million in Q4 2025 for Fulgent Genetics, down from $66.8 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $150.6 million in Q4 2022 to a low of $6.8 million in Q2 2021.
  • Historically, Intangibles has averaged $87.1 million across 5 years, with a median of $81.9 million in 2023.
  • Biggest five-year swings in Intangibles: skyrocketed 1213.44% in 2022 and later crashed 51.31% in 2025.
  • Year by year, Intangibles stood at $35.9 million in 2021, then soared by 319.45% to $150.6 million in 2022, then decreased by 5.04% to $143.1 million in 2023, then crashed by 50.8% to $70.4 million in 2024, then fell by 7.95% to $64.8 million in 2025.
  • Business Quant data shows Intangibles for FLGT at $64.8 million in Q4 2025, $66.8 million in Q3 2025, and $135.3 million in Q2 2025.